Parameter | Number of patients | Before treatment | After treatment | Reference range | P value | Significance |
---|---|---|---|---|---|---|
T-cells (CD3)% of total T cells | 113 | 79.91 (6.78) | 77.67 (8.18) | 61-85 | 0.001 | In normal range but significantly decreased after treatment |
Helper T-cell (Th cell/CD4) % of total T cells | 114 | 48.84 (9.03) | 45.44 (10.65) | 28-58 | <0.001 | In normal range but significantly decreased after treatment |
Ts cell (CD8)% of total T cells | 114 | 25.38 (7.18) | 26.89 (8.10) | 19-48 | 0.005 | In normal range but significantly increased after treatment |
CD4/CD8 | 114 | 0.30 (0.20) | 0.24 (0.23) | -0.05-0.30 | <0.001 | In normal range but significantly decreased after treatment |
IgG (g/L) | 114 | 0.96 (0.12) | 0.91 (0.14) | 0.86-1.23 | <0.001 | In normal range but significantly decreased after treatment |
IgA (g/L) | 114 | 2.15 (0.79) | 2.01 (0.72) | 0.68-3.83 | <0.001 | In normal range but significantly decreased after treatment |
IgM (g/L) | 114 | 1.13 (0.62) | 1.32 (0.72) | 0.63-2.77 | <0.001 | In normal range but significantly increased after treatment |
Complement C3 (g/L) | 114 | 1.19 (0.23) | 1.21 (0.25) | 0.85-1.93 | 0.103 | In normal range but no significant changes after treatment |
Complement C4 (g/L) | 114 | -0.62 (0.17) | -0.63 (-0.16) | -0.92 - -0.44 | 0.283 | In normal range but no significant changes after treatment |